BBVA USA Bancshares, Inc. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 996 filers reported holding BAXTER INTL INC in Q2 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
BBVA USA Bancshares, Inc. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q1 2021$594,000
+117.6%
7,044
+111.0%
0.03%
+75.0%
Q2 2019$273,000
-2.8%
3,339
-3.5%
0.02%
-11.1%
Q1 2019$281,000
+23.2%
3,4590.0%0.02%
+12.5%
Q4 2018$228,000
-14.3%
3,4590.0%0.02%0.0%
Q3 2018$266,000
+9.5%
3,459
+5.4%
0.02%
+6.7%
Q2 2018$243,000
+6.6%
3,282
-6.5%
0.02%0.0%
Q1 2018$228,000
-18.3%
3,512
-18.6%
0.02%
-16.7%
Q4 2017$279,000
-5.1%
4,317
-7.9%
0.02%
-5.3%
Q3 2017$294,000
+1.0%
4,688
-2.5%
0.02%0.0%
Q2 2017$291,000
+14.1%
4,808
-2.4%
0.02%
+11.8%
Q1 2017$255,000
-7.9%
4,927
-21.3%
0.02%
-15.0%
Q4 2016$277,000
-8.9%
6,259
-2.1%
0.02%
-9.1%
Q3 2016$304,000
-0.7%
6,396
-5.5%
0.02%
-4.3%
Q2 2016$306,000
+8.1%
6,766
-1.9%
0.02%
+9.5%
Q1 2016$283,000
-33.3%
6,896
-38.1%
0.02%
-34.4%
Q4 2015$424,000
-37.3%
11,135
-46.0%
0.03%
-39.6%
Q3 2015$676,000
-75.4%
20,604
-47.6%
0.05%
-65.4%
Q2 2015$2,748,000
-32.7%
39,298
-34.1%
0.15%
-15.9%
Q1 2015$4,083,000
-6.9%
59,610
-0.4%
0.18%
-8.5%
Q4 2014$4,386,000
+4.1%
59,836
+2.0%
0.20%
+5.9%
Q3 2014$4,212,000
+1.8%
58,688
+2.6%
0.19%
+4.4%
Q2 2014$4,136,000
+2.5%
57,207
+4.3%
0.18%
-2.2%
Q1 2014$4,034,000
+3.4%
54,832
-2.3%
0.18%
+8.2%
Q4 2013$3,902,000
+5.2%
56,106
-0.6%
0.17%
-4.0%
Q3 2013$3,709,000
-7.1%
56,464
-2.1%
0.18%
-12.4%
Q2 2013$3,993,00057,6490.20%
Other shareholders
BAXTER INTL INC shareholders Q2 2015
NameSharesValueWeighting ↓
GENERATION INVESTMENT MANAGEMENT LLP 21,171,371$1,817,350,0007.47%
Soditic Asset Management LLP 147,620$12,672,0006.53%
NUANCE INVESTMENTS, LLC 4,084,218$350,589,0006.17%
PRAGMA GESTAO DE PATRIMONIO LTD 145,000$12,4475.96%
Veritas Asset Management LLP 12,222,261$1,049,159,0005.89%
Pavadi Capital LLC 72,782$6,248,0004.74%
Sonen Capital LLC 48,907$4,198,0004.06%
Glenview Capital Management 2,182,422$187,339,0003.99%
Dash Acquisitions Inc. 103,963$8,924,0003.87%
Avidity Partners Management LP 1,765,000$151,508,0003.21%
View complete list of BAXTER INTL INC shareholders